Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury

References

• Alexandre J, Rey E, Girre V, et al (2007). Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Ann Oncol 18:168–72.
   PubMed Web of Science ®Google Scholar
• Alfaro CL. (2001). Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown. Psychopharmacol Bull 35:80–93.
   PubMedGoogle Scholar
• Andrade RJ, Lucena MI, Alonso A, et al (2004). HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39:1603–12.
   PubMed Web of Science ®Google Scholar
• Anonymous. (1997). FDA announces plan to halt marketing of terfenadine. Am J Health Syst Pharm 54:342–7.
   PubMed Web of Science ®Google Scholar
• Anonymous. (1998). Roche, FDA announce new drug-interaction warnings for mibefradil. Am J Health Syst Pharm 55:208–10
   PubMed Web of Science ®Google Scholar
• Arase Y, Ikeda K, Murashima N, et al (1997). The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79:1494–500.
   PubMed Web of Science ®Google Scholar
• Bao QD, Yang LL, Wang L, Cui DL. (2008). Protective effects of magnesium isoglycyrrhizinate against carbon tetrachloride-induced acute liver injury in mice. World Chin J Digestol 16:1004–7.
   Google Scholar
• Bogacz A, Mrozikiewicz PM, Karasiewicz M, et al (2014). The influence of standardized Valeriana officinalis extract on the CYP3A1 gene expression by nuclear receptors in in vivo Model. Biomed Res Int 2014:819093.
   PubMed Web of Science ®Google Scholar
• Chen KJ, Chen WY, Chen X, et al (2014). Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study. Eur J Drug Metab Pharmacokinet 39:25–31.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang J, Davey AK, et al (2009). Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism. Xenobiotica 39:955–63.
   PubMed Web of Science ®Google Scholar
• Choi YH, Suh JH, Lee JH, et al (2010). Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats. J Pharm Pharmacol 62:1084–8.
   PubMed Web of Science ®Google Scholar
• Cline DJ, Zhang H, Lundell GD, et al (2013). An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma. Ther Drug Monit 35:803–8.
   PubMed Web of Science ®Google Scholar
• Dorr RT. (1997). Pharmacology of the taxanes. Pharmacotherapy 17:96S–104S.
   PubMed Web of Science ®Google Scholar
• Fang Y, Wang L, Xia GH, et al (2014). Clinical investigation of efficacy of albumin bound paclitaxel plus platinum compounds as first-line chemotherapy for stage III/IV squamous non-small cell lung cancer. Asian Pac J Cancer Prev 15:7453–7.
   PubMedGoogle Scholar
• Feng X, Ding L, Qiu F. (2015). Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid. Drug Metab Rev 47:229–38.
   PubMed Web of Science ®Google Scholar
• Fu D. (2013). Where is it and how does it get there – intracellular localization and traffic of P-glycoprotein. Front Oncol 3:321.
   PubMedGoogle Scholar
• Goey AK, Meijerman I, Rosing H, et al (2014). The effect of St John’s wort on the pharmacokinetics of docetaxel. Clin Pharmacokinet 53:103–10.
   PubMed Web of Science ®Google Scholar
• He Y, Zeng F, Liu Q, et al (2010). Protective effect of magnesium isoglycyrrhizinate on ethanol-induced testicular injuries in mice. J Biomed Res 24:153–60.
   PubMedGoogle Scholar
• Hou YC, Lin SP, Chao PD. (2012). Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP3A. Food Chem 135:2307–12.
   PubMed Web of Science ®Google Scholar
• Huang P, Wang D, Su Y, et al (2014). Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc 136:11748–56.
   PubMed Web of Science ®Google Scholar
• Konig J, Muller F, Fromm MF. (2013). Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65:944–66.
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (1998). Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–90.
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (2001). Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol 41:535–67.
   PubMed Web of Science ®Google Scholar
• Liu SY, Wang QM, Cao C, et al (2006). Simultaneous measurement of magnesium isoglycyrrhizinate and glycyrrhetic acid in plasma of dog by HPLC. Chin J Clin Pharmacol Ther 11:1395–400.
   Google Scholar
• Liu W, Gao FF, Li Q, et al (2014). Protective effect of astragalus polysaccharides on liver injury induced by several different chemotherapeutics in mice. Asian Pac J Cancer Prev 15:10413–20.
   PubMedGoogle Scholar
• Martignoni M, Groothuis G, de Kanter R. (2006). Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos 34:1047–54.
   PubMed Web of Science ®Google Scholar
• Mielke S, Sparreboom A, Steinberg SM, et al (2005). Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer. Clin Cancer Res 11:4843–50.
   PubMed Web of Science ®Google Scholar
• Nallani SC, Goodwin B, Buckley AR, et al (2004). Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes. Cancer Chemother Pharmacol 54:219–29.
   PubMed Web of Science ®Google Scholar
• Ni HC, Xe YY, Feng WD. (2009). Effect of magnesium isoglycyrrhizinate in the treatment of the hepatotoxicity caused by anti-tumor agents in cancer patients. Anhui Med Pharm J 13:1099–100.
   Google Scholar
• Preissner S, Dunkel M, Hoffmann MF, et al (2012). Drug cocktail optimization in chemotherapy of cancer. PLoS One 7:e51020.
   PubMed Web of Science ®Google Scholar
• Shou M, Martinet M, Korzekwa KR, et al (1998). Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver. Pharmacogenetics 8:391–401.
   PubMedGoogle Scholar
• Song JW, Xing R. (2012). Pharmacological effects and clinical application of magnesium isoglycyhirrzinate. Chin J New Drugs Clin Rem 31:578–82.
   Google Scholar
• Song W. (2011). Effect of magnesium isoglycyrrhizinate and tiopronin on preventing hepatic injury induced by chemotherapy in breast cancer. J Clin Med Pract 15:73–5.
   Google Scholar
• Tai T, Huang X, Su Y, et al (2014). Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats. J Ethnopharmacol 152:358–63.
   PubMed Web of Science ®Google Scholar
• Tu JH, He YJ, Chen Y, et al (2010). Effect of glycyrrhizin on the activity of CYP3A enzyme in humans. Eur J Clin Pharmacol 66:805–10.
   PubMed Web of Science ®Google Scholar
• van Rossum TG, Vulto AG, Hop WC, et al (1999). Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 14:1093–9.
   PubMed Web of Science ®Google Scholar
• Veldt BJ, Hansen BE, Ikeda K, et al (2006). Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon. Scand J Gastroenterol 41:1087–94.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liang X, Yu J, et al (2012). Non-genetic risk factors and predicting efficacy for docetaxel-drug-induced liver injury among metastatic breast cancer patients. J Gastroenterol Hepatol 27:1348–52.
   PubMed Web of Science ®Google Scholar
• Wei Y, Guan J, Ma X, et al (2015). Effect of glycyrrhizic acid on rhein renal penetration: a microdialysis study in rats. Xenobiotica 45:1116–21.
   PubMed Web of Science ®Google Scholar
• Wen J, Wang Y, Yang L, et al (2014). Comparative pharmacokinetic study of four major components after oral administration of pure compounds, herbs and Si-Ni-San to rats. Xenobiotica 44:855–60.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Liu Y, Zhang JW, et al (2009). C-7 configuration as one of determinants in taxanes metabolism by human cytochrome P450 enzymes. Xenobiotica 39:903–14.
   PubMed Web of Science ®Google Scholar
• Zou W, Zhou W. (2007). Metabolic drug interactions. Food Drug 9:46–9.
   Google Scholar